Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide

Infection
A DalhoffU Ullmann

Abstract

Antibiotic activity against common respiratory pathogens can be affected by the pH of the medium (in vitro) or the bodily fluid (in vivo) in which bacteria are present. The ionized fraction of an antibiotic is not able to efficiently penetrate bacterial or mammalian membranes, reducing the quantity of molecules able to exert their antibacterial effect resulting in elevated MIC values This study shows that the activity of macrolide antibiotics is particularly sensitive to acidic conditions, whereas a ketolide and fluoroquinolones are much less affected. Furthermore, induction of spontaneous and multistep macrolide resistance is greatly increased in acidic medium. In contrast, telithromycin and moxifloxacin did not induce resistance at any pH. Antibiotics which are less likely to induce resistance in vitro may also be less likely to induce the development of resistance in patients with respiratory tract infections.

Citations

Sep 5, 2013·The Journal of Antibiotics·Mark S ButlerMatthew A Cooper
Aug 10, 2012·The Journal of Antimicrobial Chemotherapy·Joan M RemyJoseph A Devito
Jun 29, 2011·Antimicrobial Agents and Chemotherapy·Will StubbingsHarald Labischinski
Mar 25, 2008·Therapeutics and Clinical Risk Management·David Rp Guay
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Mar 19, 2014·The American Journal of Medicine·Tyler BrownLorrel Brown
Mar 17, 2015·Advanced Drug Delivery Reviews·Jatinder Kaur MukkerHartmut Derendorf
Jul 16, 2010·International Journal of Antimicrobial Agents·Axel Dalhoff, Sabine Schubert
Oct 27, 2009·European Journal of Pharmacology·Maria SaroglouDemosthenes Bouros
Jun 30, 2016·The Journal of Antibiotics·Mark S ButlerMatthew A Cooper
May 17, 2018·Future Microbiology·Matteo BassettiGlenn Tillotson
Aug 13, 2013·The Cochrane Database of Systematic Reviews·Gianpaolo PerlettiVittorio Magri
Nov 22, 2017·Antimicrobial Agents and Chemotherapy·Axel Dalhoff
Nov 15, 2007·American Journal of Rhinology·Vasilios K MargaritisPanos D Goumas
Dec 11, 2013·Antimicrobial Agents and Chemotherapy·Kalliopi ChatzikaIoannis Kioumis
Oct 6, 2018·The Analyst·Holly FlemingColin J Campbell
Jun 8, 2018·American Journal of Respiratory and Critical Care Medicine·Byung Woo JhunWon-Jung Koh
Mar 14, 2007·The Journal of Antimicrobial Chemotherapy·Hoang Anh NguyenClaudine Quentin
Jan 20, 2017·Biomedical Optics Express·D ChoudhuryR R Thomson
Apr 20, 2021·Expert Review of Respiratory Medicine·Sujit Kumar DebnathAbdelwahab Omri
Jun 7, 2021·Molecular and Cellular Biochemistry·Erum MalikSarah R Dennison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.